Baiyang Investment Group, Inc. (SHE:002696)
China · Delayed Price · Currency is CNY 5.44
+0.01 (0.18%)
Aug 4, 2026, 3:04 PM CST
Baiyang Investment Group Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 4,226 | 4,055 | 3,078 | 2,720 | 3,214 | 2,905 |
Revenue Growth | 29.55% | 31.76% | 13.14% | -15.36% | 10.63% | 17.03% |
Gross Profit Gross Profit Growth | 311.67 | 323.95 | 266.39 | 218.38 | 379.22 | 298.52 |
Operating Income Operating Income Growth | 66.89 | 64.22 | -1.69 | -27.55 | 80.16 | 33.19 |
Net Income Net Income Growth | 16.86 | 40.63 | -15.25 | -27.59 | 62.34 | 26.83 |
Earnings Per Share EPS Growth | 0.05 | 0.12 | -0.04 | -0.08 | 0.18 | 0.08 |
EPS Growth | - | - | - | - | 125.00% | 33.33% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Deep-Sea Fishing Deep-Sea Fishing Growth | 298.29 |
Food Processing Food Processing Growth | 3,074 |
Feed and Raw Materials Feed and Raw Materials Growth | 2,638 |
Other Other Growth | 5.05 |
Inter-Segment Elimination Inter-Segment Elimination Growth | -2,008 |
Biological Products Biological Products Growth | 48.28 |
Total Total Growth | 4,055 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 567.84 | 408.89 | 455.14 | 620.49 | 332.53 | 249.55 |
Total Debt Total Debt Growth | 1,981 | 1,446 | 1,173 | 1,110 | 741.02 | 922.83 |
Net Cash (Debt) Net Cash Growth | -1,413 | -1,037 | -718.33 | -489.27 | -408.5 | -673.28 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -4.08 | -2.99 | -2.07 | -1.42 | -1.18 | -2.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -371.09 | -315.24 | -60.18 | 240.06 | 176.6 | -22.26 |
Capital Expenditures CapEx Growth | -205.51 | -186.72 | -110.39 | -87.79 | -74.77 | -72.99 |
Free Cash Flow Free Cash Flow Growth | -576.59 | -501.96 | -170.56 | 152.27 | 101.83 | -95.25 |
Free Cash Flow Growth | - | - | - | 49.53% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 7.38% | 7.99% | 8.65% | 8.03% | 11.80% | 10.27% |
Operating Margin | 1.58% | 1.58% | -0.06% | -1.01% | 2.49% | 1.14% |
Pretax Margin | 0.37% | 0.88% | -0.33% | -1.44% | 1.95% | 0.94% |
Profit Margin | 0.40% | 1.00% | -0.50% | -1.01% | 1.94% | 0.92% |
FCF Margin | -13.64% | -12.38% | -5.54% | 5.60% | 3.17% | -3.28% |
| Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 0.050 | 0.050 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 0.92% | 0.71% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 111.81 | 60.27 | - | - | 41.84 | 76.29 |
Forward PE | - | 10.19 | 10.19 | 10.19 | 10.19 | 10.19 |
P/FCF Ratio | - | - | - | 15.06 | 25.61 | - |
PS Ratio | 0.45 | 0.60 | 0.53 | 0.84 | 0.81 | 0.71 |